PDRN: The DNA-Based Ingredient for Skin Regeneration
SKIN Define

PDRN: The DNA-Based Ingredient for Skin Regeneration

By Sophie · · PDRN (Polydeoxyribonucleotide)

PDRN (Polydeoxyribonucleotide)

PDRN (polydeoxyribonucleotide) is a mixture of short DNA chains produced by enzymatic hydrolysis of salmon testis DNA. It stimulates fibroblast activity, collagen and elastin synthesis, and anti-inflammatory signaling through two primary pathways: the purine salvage cycle and A2A adenosine receptor activation. First brought to clinical use by Korean dermatology as the “Rejuran Healer” injectable, PDRN is now found in serums, ampoules, and premium skincare globally.

  • Category: skin, longevity
  • Related: polynucleotide (PN), Rejuran, skin booster, fibroblast, collagen, K-beauty

What PDRN Is

PDRN is derived from the testis of salmon (Oncorhynchus species), extracted as DNA and then enzymatically fragmented into short nucleotide chains. Molecular weight ranges from approximately 50 to 2,000 kDa, a range that supports both receptor binding activity and meaningful percutaneous absorption.

PDRN and PN (polynucleotide) are frequently used interchangeably in marketing, but they refer to different things. PDRN is defined by a specific molecular weight range and manufacturing standard. PN is a broader category of nucleotide polymers. Not all PN products are equivalent to clinical-grade PDRN.

How It Works

Purine Salvage Pathway Cells absorb PDRN fragments and break them down into raw nucleotide materials, which are then reused for DNA repair, cellular proliferation, and energy metabolism. This effectively replenishes the building block supply for tissue regeneration, particularly relevant when skin repair capacity has declined with age or damage.

A2A Adenosine Receptor Activation Adenosine released from PDRN breakdown binds to A2A receptors on skin cells, switching on anti-inflammatory signaling cascades. The same pathway stimulates VEGF (vascular endothelial growth factor) production, promoting angiogenesis, the formation of new blood vessels that improve nutrient and oxygen delivery to skin tissue.

Both pathways together drive: fibroblast proliferation, collagen and elastin synthesis, reduced inflammatory cytokines, and improved microcirculation.

What the Evidence Shows

Wrinkle Reduction and Skin Regeneration A 2026 PMC review of multiple controlled trials documented an average 67% improvement in wrinkle depth from injectable PDRN. Topical PDRN formulations reached approximately 78% of injectable efficacy overall, with 52% wrinkle depth improvement compared to 67% for injectables.

Hyperpigmentation Melanin synthesis inhibition through the A2A pathway has been studied for melasma and UV-induced pigmentation, with clinical data continuing to develop for both injectable and topical routes.

Wound Healing and Scarring Post-surgical wound closure, acne scar improvement, and atopic skin barrier reinforcement have documented clinical support. Anti-inflammatory effects are specifically relevant for scar tissue formation.

Hair Regeneration Scalp blood vessel formation and follicle environment improvement through PDRN injection are being studied in hair loss applications. Clinic use is ahead of published data in this area.

From Clinic to Consumer: The K-Beauty Path

Korean dermatology clinics introduced PDRN as “Rejuran Healer” skin booster injections in the early 2010s, building a clinical track record that preceded the ingredient’s appearance in consumer skincare. Multiple PDRN formulations hold Korean MFDS approval. As the data accumulated, topical formulations were developed and the ingredient followed the same globalization path as niacinamide, centella asiatica, and other K-beauty-pioneered actives.

Tetrapod Guide

What to look for in products

  • “PDRN” or “polydeoxyribonucleotide” on the ingredient label
  • Concentration: typically 0.1 to 1%
  • Origin documentation: Korean MFDS-approved raw materials indicate stronger quality standards
  • Delivery technology: nanosphere, liposome, or penetrating peptide encapsulation for topical products

Salmon allergy considerations Allergenic proteins, including parvalbumin, are removed during the purification process. General clinical tolerance is good. Individuals with significant salmon allergies should perform a patch test or consult a dermatologist.

Injectable vs. topical With topical PDRN reaching approximately 78% of injectable efficacy in current data, topical products are a meaningful option for maintenance and for those avoiding in-clinic procedures. Formulations using nanosome or liposome encapsulation generally demonstrate better absorption than simple aqueous solutions.